Génome Québec — Commercialization Priming
- Open continuously
Overview
The Génome Québec — Commercialization Priming program provides funding of up to $100,000 over 12 months to support early-stage efforts in testing or validating the commercial viability of innovations related to D2R Initiative's priority areas. The program targets projects that demonstrate potential for commercial success and align with D2R's strategic objectives, including those capable of securing further funding or investment.
At a glance
Funding available
- Reduce environmental footprint
- Maximum amount : 100,000 $
- Minimum amount : 50,000 $
- Up to 27% of project cost
- Open continuously
Eligible candidates
- Professional, scientific and technical services
- Quebec
- All legal structures
- All revenue ranges
- All organization sizes
- Indigenous Peoples
- Persons with Disabilities
- Language Minorities
- Other Racialized Persons
- Black Canadians
- Canadians
- Women
Next Steps
Activities funded
- Testing or validating the commercial potential of well-defined concepts, technologies, or inventions tied to the D2R Initiative’s priority areas.
- Projects aligned with D2R’s mission and strategic priorities.
- Projects that demonstrate potential for commercial viability.
- Projects with a well-defined strategy for testing or validating commercial potential, including a clear workplan.
- Projects capable of reaching proof of concept or advancing to a higher technology readiness level within the funding period and budget.
- Projects with the potential to secure further funding for technology development and commercialization, possibly leading to university spin-offs.
Eligibility
Who is eligible?
The Génome Québec Commercialization Priming program is primarily open to the following individuals and groups:1. Principal Investigators (PI): - Faculty members at McGill University holding the role of Assistant Professor, Associate Professor, or Full Professor. - Eligible to hold Tri-Agency research funding.2. Co-Investigators (Co-I): - Faculty members at McGill University with positions as Assistant Professor, Associate Professor, or Full Professor. - Researchers from D2R’s partner institutions, including McMaster University, the University of British Columbia, the University of Ottawa, and Université de Sherbrooke, who are on the approved list by partners. - Eligible to hold Tri-Agency research funding.3. Collaborators: - Individuals from McGill, other academic institutions, industry, government, or community organizations who contribute meaningfully to the project. - Not eligible to receive funding from D2R.4. Partner Organizations: - Organizations such as government entities, industries, associations, non-profit organizations, or other institutions contributing or committing cash or in-kind support for the proposed research.However, the program does not explicitly specify eligibility criteria for particular company types or industry sectors other than those collaborators and partner organizations may represent.
Eligible expenses
- Salaries and benefits.
- Stipends.
- Materials and supplies.
- Travel expenses.
- Service contracts.
Additional information
- Applications that involve Génome Québec funding must remit one-sixth (1/6) of the Net Revenues from the commercialization of Intellectual Property resulting from funded projects back to Génome Québec.
- Final decisions on funding are made by the D2R Research Steering Committee, considering both the evaluation committee's report and alignment with D2R's strategic goals.
- Applicants are informed of the funding decision within two months of the application deadline.
- Successful applicants must complete all necessary documentation and approvals, including ethics, biohazards, and animal care, before the disbursement of funds.
- There are no restrictions on the number of applications a Principal Investigator or Co-Investigator can submit to the program.